Leadership Overview
Cynosure has 10 executives leading key functions including strategy, finance, technology, legal, operations, and sales.
Driven by innovation, [[Cynosure]] develops and manufactures energy-based aesthetic and medical treatment systems, enhancing offerings for practitioners and providing advanced treatments to patients worldwide.
Driven by innovation, [[Cynosure]] develops and manufactures energy-based aesthetic and medical treatment systems, enhancing offerings for practitioners and providing advanced treatments to patients worldwide.
Leadership Roles at Cynosure Lutronic
Timothy Gehlmann - Chief Executive Officer & President, Hoya Photonics Inc & of Hoya Photonics Inc
Timothy Gehlmann, the Chief Executive Officer & President, Hoya Photonics Inc & of Hoya Photonics Inc at Cynosure, directs the strategic vision and operational execution for the company's photonics division. This leadership role involves guiding product development, market expansion, and financial performance within the specialized photonics sector. Gehlmann oversees the integration of advanced optical technologies into Cynosure's broader portfolio of energy-based aesthetic and medical treatment systems. The focus remains on leveraging cutting-edge photonics to create innovative solutions for hair removal, skin revitalization, and other medical applications. Timothy Gehlmann ensures alignment with the parent company's mission to deliver best-in-class creators of energy-based aesthetic and medical treatment systems. This executive's purview extends to fostering key partnerships and driving technological advancements that solidify Cynosure's market leadership in the aesthetic and medical device industry.
Cyriacus Njoku - Chief Executive Officer & President
Cyriacus Njoku, the Chief Executive Officer & President at Cynosure, architects the overarching corporate strategy and drives operational excellence across the organization. This executive guides the company's mission to be leaders, innovators, and creators of energy-based aesthetic and medical treatment systems. Njoku's responsibilities encompass overseeing the development and manufacturing of a diverse range of treatment applications, including those for hair removal, skin revitalization, scar reduction, gynecological health, and body contouring. The strategic direction set by Cyriacus Njoku ensures that Cynosure's innovative products are utilized worldwide by practitioners, physicians, and aesthetic business owners. This leadership ensures the company continues to provide the latest treatments to patients, enhancing the offerings of its global clientele. Cyriacus Njoku's vision propels Cynosure's commitment to advancing aesthetic and medical technology.
Robert Howe - Chief Financial Officer
Robert Howe, the Chief Financial Officer at Cynosure, directs all financial operations and fiscal strategy for the company. This critical role involves managing financial planning, budgeting, forecasting, and reporting to ensure the fiscal health and sustainable growth of Cynosure's diverse range of treatment systems. Howe oversees capital allocation, investment strategies, and risk management, directly supporting the company's position as a leader in energy-based aesthetic and medical devices. The financial guidance provided by Robert Howe is essential for the company's global expansion and its ability to fund ongoing innovation in areas like hair removal and skin revitalization. This executive ensures robust financial controls are in place, enabling practitioners and physicians worldwide to confidently utilize Cynosure's advanced offerings. Robert Howe's leadership solidifies the company's financial foundation for continued market impact.
Baker Baker - Executive Vice President & Chief Financial Officer
Baker Baker, the Executive Vice President & Chief Financial Officer at Cynosure, collaborates with the Chief Financial Officer to manage the company's extensive financial architecture. This executive role supports the strategic financial planning and execution necessary for Cynosure's operations as a leading creator of energy-based aesthetic and medical treatment systems. Baker Baker's responsibilities include overseeing financial reporting, compliance, and the optimization of financial resources across the company's product lines, such as those for gynecological health and body contouring. This executive's involvement ensures the financial integrity and efficiency required to support global practitioners and physicians. Baker Baker contributes to the fiscal strategy that underpins Cynosure's commitment to innovation and delivering best-in-class aesthetic and medical solutions. The financial oversight provided by Baker Baker is integral to the company's sustained market presence.
Scott Karten - President, Areavice of Sales (East)
Scott Karten, the President, Areavice of Sales (East) at Cynosure, leads sales initiatives and drives revenue growth across the eastern territories. This executive is responsible for developing and executing sales strategies for Cynosure's comprehensive portfolio of energy-based aesthetic and medical treatment systems. Karten oversees a dedicated sales team focused on expanding market penetration for products used in skin revitalization, scar reduction, and body contouring. The sales leadership provided by Scott Karten ensures that practitioners, physicians, and aesthetic business owners in the eastern region have access to Cynosure's innovative offerings. This role is critical for fostering strong client relationships and understanding market needs to drive adoption of the latest treatments. Scott Karten's strategic sales approach directly contributes to the company's overall success and its mission to enhance aesthetic and medical practices.
Christopher Aronson - President, North America
Christopher Aronson, the President, North America at Cynosure, directs the strategic growth and market leadership within the North American region. This executive oversees all commercial activities, including sales, marketing, and business development for Cynosure's advanced energy-based aesthetic and medical treatment systems. Aronson's leadership ensures that practitioners and physicians across the United States and Canada have access to innovative solutions for hair removal, skin revitalization, and gynecological health. The market strategies implemented by Christopher Aronson are designed to expand Cynosure's footprint and reinforce its reputation as a premier provider of medical aesthetic technology. This role is pivotal in translating the company's global vision into regional success, driving adoption of cutting-edge treatments. Christopher Aronson's focus on market dynamics strengthens Cynosure's commitment to delivering best-in-class offerings.
Lowinn Kibbey - President (North America)
Lowinn Kibbey, the President (North America) at Cynosure, drives strategic initiatives and operational performance throughout the North American market. This executive manages the expansion and market penetration of Cynosure's diverse portfolio of energy-based aesthetic and medical treatment systems. Kibbey's responsibilities include overseeing sales channels, customer engagement, and ensuring the effective delivery of innovative solutions for skin revitalization, scar reduction, and body contouring. The market leadership cultivated by Lowinn Kibbey ensures that medical professionals across North America benefit from Cynosure's cutting-edge technology. This role is essential for adapting global strategies to regional demands and fostering strong partnerships within the aesthetic and medical communities. Lowinn Kibbey's leadership reinforces Cynosure's dedication to providing best-in-class treatments and enhancing patient care through technological advancement.
Rafael Sierra - Chief Information Officer & Chief Technology Officer
Rafael Sierra, the Chief Information Officer & Chief Technology Officer at Cynosure, spearheads the company's technological vision and digital infrastructure. This executive directs the development and implementation of innovative technology solutions that enhance Cynosure's energy-based aesthetic and medical treatment systems. Sierra's purview includes managing information systems, cybersecurity, and driving technological advancements in areas such as scar reduction and body contouring. The strategic technology roadmap established by Rafael Sierra ensures that Cynosure remains at the forefront of innovation, providing practitioners and physicians with state-of-the-art tools. This leadership role is crucial for integrating advanced digital capabilities into product development and operational processes. Rafael Sierra's expertise fuels the company's commitment to creating best-in-class medical and aesthetic devices, ensuring seamless integration and superior performance for global users.
Sean Flanagan - Chief Legal Officer
Sean Flanagan, the Chief Legal Officer at Cynosure, provides comprehensive legal counsel and oversees all legal affairs for the company. This executive ensures compliance with all relevant laws and regulations governing the development, manufacturing, and distribution of energy-based aesthetic and medical treatment systems. Flanagan's responsibilities include managing intellectual property, corporate governance, and risk mitigation strategies across Cynosure's diverse product lines, including those for hair removal and skin revitalization. The legal framework established by Sean Flanagan supports the company's global operations and its relationships with practitioners, physicians, and business owners worldwide. This leadership role is vital for navigating the complex regulatory landscape of the medical device industry. Sean Flanagan's expertise safeguards Cynosure's interests and upholds its commitment to ethical business practices and product integrity.
Jae Yoo - Chief Operations Officer
Jae Yoo, the Chief Operations Officer at Cynosure, directs the company's global operational strategies and ensures efficient manufacturing and supply chain management. This executive oversees the production of Cynosure's diverse range of energy-based aesthetic and medical treatment systems, focusing on quality, scalability, and timely delivery. Yoo's responsibilities include optimizing manufacturing processes for products used in hair removal, skin revitalization, and gynecological health applications. The operational excellence driven by Jae Yoo is fundamental to Cynosure's ability to meet global demand and maintain its position as a leading innovator. This leadership role ensures that practitioners and physicians worldwide receive reliable and high-performing medical devices. Jae Yoo's focus on operational efficiency supports the company's mission to provide best-in-class solutions and enhance patient outcomes through advanced technology.
Explore Leadership Teams in Manufacturing
GE HealthCare is a global medical technology and healthcare solutions organization with a long heritage of innovation in the health care industry. The company is headquartered in the United States and has cultivated a reputation as a leading provider of technologies and services that support the diagnosis, treatment, and monitoring of patients across a wide range of clinical settings. GE HealthCare develops and delivers a broad portfolio of advanced products that includes imaging systems, patient monitoring tools, ultrasound equipment, ancillary devices used in interventional care, and pharmaceutical diagnostics that help clinicians visualize internal biological structures. The organization operates at the center of the healthcare ecosystem, aiming to improve productivity, expand access, and enhance outcomes in clinical environments by combining medical devices with digital solutions and services. Its offerings are designed to assist physicians and other healthcare professionals in delivering precise, timely, and actionable information, which supports key clinical decisions from initial screening through therapy and ongoing care. GE HealthCares technologies extend from sophisticated imaging platforms and visualization systems to remote patient monitoring solutions powered by data analytics and cloud-enabled tools.
Company Leadership
MG
Gentell, Inc. manufactures and supplies wound care, skin protection, and sanitizing products for hospitals, nursing homes, and home health agencies. The company offers wound care products, skincare products, hydrogel, collagen dressings, gauze dressings, foam dressings, alginate dressings, hydrocolloid and transparent dressings, silver products, tube and peg dressings, soaps and sanitizers, body lotions, barrier creams/incontinence, odor eliminators, and bundles for wound care. It offers its products through representatives, as well as online.
Company Leadership GT
BS
CooperVision is committed to helping people around the world see better every day. Through scientific and technological innovation, operational excellence and close working relationships with our eye care professional customers, CooperVision has helped improve the vision of millions and become a trusted global leader in the contact lens industry. CooperVision designs and manufactures innovative, high quality contact lenses to meet a remarkably wide range of wearer needs. We conduct extensive ongoing research and development in optical science. And we collaborate closely with eye care professionals, who help us identify the evolving needs of contact lens wearers around the world.
Company Leadership RA
SR
CH
JC
MSA Worldwide, LLC is a global manufacturer of advanced safety products and technology solutions designed to protect people and infrastructure in hazardous environments. The company develops equipment such as gas detection systems, respiratory protection, firefighting gear, and fall protection devices. Serving industries including oil and gas, construction, mining, and emergency services, it focuses on innovation, reliability, and performance to enhance workplace safety and operational efficiency worldwide.
Company Leadership
VK
JB
Frequently Asked Questions Regarding Cynosure Lutronic Top Executives and Leadership Team
Unlock more people and company data
